Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 12-2020 | |
| Operating Expenses | 19,898 | 0 | 10,427 | 0 |
| Operating Income | -19,898 | N/A | -10,427 | N/A |
| Other Income | -4,474 | 0 | -8,355 | 0 |
| Pre-tax Income | -24,372 | 0 | -18,782 | 0 |
| Income Tax | -532 | N/A | -2,370 | N/A |
| Net Income Continuous | -23,840 | N/A | -16,412 | N/A |
| Net Income | $-23,840 | $N/A | $-16,412 | $N/A |
| EPS Basic Total Ops | -1.58 | N/A | -1.52 | N/A |
| EPS Basic Continuous Ops | -1.25 | N/A | -1.10 | N/A |
| EPS Diluted Total Ops | -1.58 | N/A | -1.52 | N/A |
| EPS Diluted Continuous Ops | -1.25 | N/A | -1.10 | N/A |
| EBITDA(a) | $-19,412 | $N/A | $-10,427 | $N/A |